Cohance Lifesciences Limited (NSE:COHANCE)

India flag India · Delayed Price · Currency is INR
1,068.35
-2.30 (-0.21%)
Jul 22, 2025, 11:39 AM IST
30.19%
Market Cap409.60B
Revenue (ttm)11.98B
Net Income (ttm)2.68B
Shares Out382.57M
EPS (ttm)10.45
PE Ratio102.45
Forward PE63.34
Dividendn/a
Ex-Dividend Daten/a
Volume11,070
Average Volume307,306
Open1,079.00
Previous Close1,070.65
Day's Range1,060.50 - 1,079.00
52-Week Range815.05 - 1,360.00
Beta0.81
RSI58.48
Earnings DateAug 8, 2025

About Cohance Lifesciences

Cohance Lifesciences Limited engage in the end-to-end contract development and manufacturing of intermediates and active pharmaceutical ingredients in India. The coampny offers active pharmaceutical ingredients and formulations for various applications; CDMO services, a flexible and custom solutions for challenging development and manufacturing needs; and clinical, analytical, and research services. It also manufactures finished dosage formulations for pharmaceutical companies; and specialty chemicals, such as electronic chemicals. The company ... [Read more]

Sector Healthcare
Founded 1989
Employees 1,193
Stock Exchange National Stock Exchange of India
Ticker Symbol COHANCE
Full Company Profile

Financial Performance

In 2024, Cohance Lifesciences's revenue was 11.98 billion, an increase of 13.91% compared to the previous year's 10.51 billion. Earnings were 2.68 billion, a decrease of -10.79%.

Financial Statements

News

There is no news available yet.